13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer’s Disease.
Mekkittikul M, Zhu C, Danna BT, Xiaohong Z, Rios A, Yang K, Villanueva M, Agarwal D, Castro D, Gu X, Strofs AR, Shirihai OS, Stiles L, Frautschy SA, Oscarsson J, Esterline RL, Cole GM, and Divakaruni AS. (2025) 13C tracing in synaptosomes reveals that SGLT2 inhibition with dapagliflozin prevents metabolic deficits in the 5X-FAD model of Alzheimer’s Disease. bioRxiv [Preprint]. 2025.04.30.651373. 40654760


